Oxartis in partnership with UCL, are launching a landmark product development project supported by an IUK Biomedical Catalyst grant. The grant provides £630,000 of a total project cost of £860,000, to support the pre-clinical development of ProMatrix BioDerm, Oxartis’ lead tissue scaffold product. The collaboration with Dr Linh Nguyen, at the Eastman Dental Institute at University College Hospital, will support the development with some of the nation’s top expertise and technology.
These grants are incredibly competitive, and we are delighted to have been selected as winners. Although it is tough to raise co-funding at an early stage of product development, we are honoured to be able use IUK support to address an urgent un-met clinical need for effective skin reconstruction.
Securing this grant funding has enable Oxartis to establish a laboratory facility at Heyford Park Innovation Centre in the Oxfordshire technology belt, and start work on developing its first clinical product.
